Boehringer 1218-0091 – DINAMO

Enroll Now

Type of Study:

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Title of Study:

Boehringer 1218-0091

Short Title:

DINAMO

Study Length: 1 year

Target Age/Sex: aged 10 to below 18 years

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: Clinicaltrials.gov